Do clinical outcomes in individuals with malignant gliomas differ between sexes?
- PMID: 39834719
- PMCID: PMC11743585
- DOI: 10.1016/j.bas.2024.104172
Do clinical outcomes in individuals with malignant gliomas differ between sexes?
Abstract
Introduction: Sex-related differences in the epidemiology of malignant gliomas are acknowledged; however, information regarding their clinical characteristics and outcomes after surgery is limited.
Research question: To identify sex-specific differences of all patients with high-grade glioma at our institution and assessed clinical outcomes and prognostic factors.
Material and methods: This single-center study included those who underwent surgery for malignant gliomas between 2010 and 2020. Categorical, normally distributed, and skewed continuous variables were compared between men and women using the chi-square test, independent samples t-test, and Mann-Whitney U test, respectively. Survival was calculated using the log-rank and Kaplan-Meier methods.
Results: In total, 621 patients with WHO grade IV gliomas were identified (370 (59.58%) male). Men were significantly younger, underwent surgery faster after imaging diagnosis, and had a slightly higher surgical complications incidence than women. Women reported a worse preoperative performance status. Multivariate analysis showed that sex did not affect survival, surgical complications, nicotine or alcohol abuse, or preoperative tumor volume. Age, Karnofsky performance status, neurosurgical resection, and adjuvant radiotherapy with temozolomide showed a survival advantage.
Discussion and conclusions: Men are diagnosed with malignant glioma at a younger age than women; however, no advantage in clinical outcomes was observed. No sex-related differences were observed.
Keywords: Anaplastic oligodendroglioma; Diffuse astrocytoma; Gliosarcoma; High-grade glioma; Sex differences.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.J Neurosurg. 2018 Jul;129(1):1-9. doi: 10.3171/2017.3.JNS162383. Epub 2017 Sep 8. J Neurosurg. 2018. PMID: 28885120
-
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9. doi: 10.1016/j.ijrobp.2005.01.056. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168843
-
Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.J Neurooncol. 2019 Jan;141(2):383-391. doi: 10.1007/s11060-018-03044-4. Epub 2018 Nov 29. J Neurooncol. 2019. PMID: 30498891
-
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update.J Neurooncol. 2025 Mar;172(1):99-152. doi: 10.1007/s11060-024-04871-4. Epub 2025 Jan 13. J Neurooncol. 2025. PMID: 39806106
-
The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.J Neurooncol. 2015 Dec;125(3):551-83. doi: 10.1007/s11060-015-1948-1. Epub 2015 Nov 3. J Neurooncol. 2015. PMID: 26530266
References
LinkOut - more resources
Full Text Sources